Notes
PharmacoEconomics & Outcomes News provides comprehensive coverage of the biomedical literature on health economics and outcomes research, and summarizes information selected from over 1600 journals. The use of tradenames, identified by [‘∼’] or the use of a registered (®) or trade mark (™), is for product identification purposes only and does not imply endorsement.
Costs were those related to inpatient care only.
The study received financial support from Servier Laboratories.
Financial support was received for the study from Eli Lilly and Company, US, with which one of the researchers was affiliated.
References
References
Huang QR. Creating informed consumers and achieving shared decision making: empowering consumers with health information on the internet. Aust Fam Phys 2003 May; 32: 335–41
References
Stafford RS, Radley DC. National trends in antiobesity medication use. Arch Intern Med 2003 May 12; 163: 1046–50
References
Maldonado MR, Chong ER, Oehl MA, et al. Economic impact of diabetic ketoacidosis in a multiethnic indigent population: analysis of costs based on the precipitating cause. Diabetes Care 2003 Apr 26: 1265-9
References
Duffy BK, Phillips PA, Davis SM, Stroke in Hospitals: an Australian Review of Treatment (START) investigators, et al. Evidence-based care and outcomes of acute stroke managed in hospital speciality units. Med J Aust 2003 Apr 7; 178: 318–23
References
Cuffel BJ, Azocar F, Tomlin M, et al. Remission, residual symptoms, and nonresponse in the usual treatment of major depression in managed clinical practice. J Clin Psychiatry 2003 Apr 64: 397-402
References
Gibbs TS, Fleischer Jr AB, Feldman SR, et al. Health care utilization in patients with migraine: demographics and patterns of care in the ambulatory setting. Headache 2003 Apr; 43: 330-5
References
Toth EL, Majumdar SR, Guirguis LM, et al. Compliance with clinical practice guidelines for type 2 diabetes in rural patients: treatment gaps and opportunities for improvement. Pharmacotherapy 2003 May; 23: 659–65
References
Crealey GE, Sturgess IK, McElnay JC, et al. Pharmaceutical care programmes for the elderly: economic issues. Pharmacoeconomics 2003; 21(7): 455–65
References
Chobanian AV, Bakris GL, Black HR, National High Blood Pressure Education Program Coordinating Committee, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 Report. JAMA 2003 May 21; 289: 2560–72
NIH hypertension guidelines recommend newer therapies for certain high risk conditions. Health News Daily [online] 2003 May 15. Available from URL: http://www.healthnewsdaily.com
Hopkins Tanne J. US guidelines say blood pressure of 120/80 mm Hg is not normal. BMJ 2003 May 24; 326: 1104
References
The coming crisis of long-term care. Lancet 2003 May 24; 361: 1755
Rights and permissions
About this article
Cite this article
Disease Management Update. Dis-Manage-Health-Outcomes 11, 541–544 (2003). https://doi.org/10.2165/00115677-200311080-00006
Published:
Issue Date:
DOI: https://doi.org/10.2165/00115677-200311080-00006